Latest Articles

Publication Date
All News Scientific
‘Actress Amy Schumer, 44, Recent Colonoscopy Helps Reduce Cancer Risks By Wiping Out Precancerous Polyps Proactively, But She Says Her Procedure Left Her Recovering Longer Than Expected - SurvivorNet

‘Actress Amy Schumer, 44, Recent Colonoscopy Helps Reduce Cancer Risks By Wiping Out Precancerous Polyps Proactively, But She Says Her Procedure Left Her Recovering Longer Than Expected SurvivorNet

Published: May 19, 2026, 9:40 p.m.
Read Full Article
Amy Schumer reveals 'botched' procedure following 50-lb weight loss - HELLO! Magazine

Amy Schumer reveals 'botched' procedure following 50-lb weight loss HELLO! Magazine

Published: May 19, 2026, 12:06 a.m.
Read Full Article
Merck's Sac-TMT Shows Promise in Advanced Endometrial Cancer Tri - GuruFocus

Merck's Sac-TMT Shows Promise in Advanced Endometrial Cancer Tri GuruFocus

Published: May 18, 2026, 11:38 p.m.
Read Full Article
Merck announces trial results for ADC that addresses unmet needs for patients with advanced endometrial cancer - PharmaLive

Merck announces trial results for ADC that addresses unmet needs for patients with advanced endometrial cancer PharmaLive

Published: May 18, 2026, 1:38 p.m.
Read Full Article
Sacituzumab Tirumotecan Improves Survival in Advanced Endometrial Cancer - Targeted Oncology

Sacituzumab Tirumotecan Improves Survival in Advanced Endometrial Cancer Targeted Oncology

Published: May 18, 2026, 1:33 p.m.
Read Full Article
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Business Wire

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Business Wire

Published: May 18, 2026, 10:45 a.m.
Read Full Article
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Yahoo! Finance Canada

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Yahoo! Finance …

Published: May 18, 2026, 10:45 a.m.
Read Full Article
Woman who had ovary removed files first court action against disgraced gynaecologist - SMH.com.au

Woman who had ovary removed files first court action against disgraced gynaecologist SMH.com.au

Published: May 15, 2026, 7 p.m.
Read Full Article
‘I just wanted contraception’: Holly’s ordeal with disgraced gynaecologist leads to Supreme Court - SMH.com.au

‘I just wanted contraception’: Holly’s ordeal with disgraced gynaecologist leads to Supreme Court SMH.com.au

Published: May 15, 2026, 7 p.m.
Read Full Article
In-Office Nitrous Oxide Linked to Fewer OR Ob/Gyn Procedures - Medscape

In-Office Nitrous Oxide Linked to Fewer OR Ob/Gyn Procedures Medscape

Published: May 14, 2026, 1:22 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!